Surgery – Radioactive substance applied to body for therapy – Radioactive substance placed within body
Patent
1989-03-27
1992-01-07
Isabella, David J.
Surgery
Radioactive substance applied to body for therapy
Radioactive substance placed within body
604 4, 128659, A61N 500
Patent
active
050786733
ABSTRACT:
Methods of treating and imaging tumor sites using radiolabeled antibodies or fragments of antibodies are disclosed. Ex vivo separation of the radiolabeled antibodies is undertaken to improve image quality and treatment efficacy.
REFERENCES:
patent: Re31712 (1989-10-01), Giese
patent: 4182780 (1980-01-01), Sullivan
patent: 4444744 (1984-04-01), Goldenberg
patent: 4454106 (1984-06-01), Gansoweld
patent: 4540401 (1985-09-01), Marten
patent: 4563170 (1986-01-01), Aigner
patent: 4605394 (1986-08-01), Skurkovich
patent: 4624846 (1986-11-01), Goldenberg
patent: 4681870 (1987-07-01), Balint, Jr. et al.
patent: 4687808 (1987-08-01), Jarett et al.
patent: 4711839 (1987-12-01), Singhal
patent: 4737544 (1988-04-01), McCain et al.
patent: 4820261 (1989-04-01), Schmoll et al.
patent: 4896780 (1989-07-01), Freed et al.
Sinitsyn et al., "Rapid Blood Clearance of Biotinylated IgG After Infusion of Avidin", J. Nucl. Med., vol. 30, No. 1, pp. 66-69 (1989).
Isabella David J.
NeoRx Corporation
Reichle K. M.
LandOfFree
Selective removal of radiolabeled antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective removal of radiolabeled antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective removal of radiolabeled antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-818500